Ajmera V, Cepin S, Tesfai K, Hofflich H, Cadman K, Lopez S, et al
The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV
Results at 72 weeks: Placebo: 3.1% weight loss Tirzepatide 5 mg: 16.0% weight loss (35.3 pounds average) Tirzepatide 10 mg: 21.4% weight loss (49.7 pounds average) Tirzepatide 15 mg: 22.5% weight loss (52.3 pounds average) The percentage of participants achieving 5% or more weight loss was 89% (5 mg), 96% (10 mg), and 96% (15 mg)
The joke was on me because the nausea was horrible, and it's been so bad that I've thrown up
[7] Together, these peptides appear to engage distinct but complementary receptor pathways, converging on the regulation of GH synthesis and secretion through complex intracellular signaling networks